How Pharma Supply Chains Adapt When Faced With Disruption
Balancing cost, speed, and product integrity across multimodal logistics in the Middle East and Africa
Pharmaceutical supply chains operate in a constant balance between cost efficiency, speed, and product integrity. Traditionally, ocean freight has served as a cost-effective backbone for many shipments, while air freight ensures rapid delivery for time-sensitive and high-value goods. However, ongoing disruptions across the Middle East and Africa (MEA) are forcing companies to rethink these strategies and make critical decisions about when to shift modes—or even escalate to dedicated charter capacity.
When Is Ocean Freight Viable for Pharma Logistics?
Ocean freight remains a viable option for certain pharmaceutical products, particularly generics and non-urgent shipments with longer shelf life. It offers cost efficiency and large capacity, making it suitable for predictable and stable supply chains.
In the past, we’ve seen a shift from air to ocean to support cost efficiencies, however, in disrupted environments, extended transit times, port congestion, and temperature control challenges can significantly increase risk. Ocean freight works best when routes are stable, packaging is robust, and timelines allow for potential delays.
When Does Ocean Freight Become Too Risky?
In periods of disruption, ocean freight can introduce unpredictable delays, especially across congested or rerouted shipping lanes. For temperature-sensitive pharmaceuticals, this increases the risk of exposure to uncontrolled conditions and prolonged transit durations.
When shipment timelines become uncertain or exceed validated packaging capabilities, ocean freight may no longer be suitable. At this point, companies must consider escalating to faster and more controlled transport modes.
When Do Pharma Companies Shift From Ocean To Air Freight?
Pharmaceutical companies typically shift from ocean to air freight when delays threaten product integrity, shelf life, or market supply. This decision is often driven by a combination of factors, including urgency, product sensitivity, regulatory requirements, and patient demand.
Air freight provides faster transit times, higher reliability, and improved temperature control. In disrupted MEA corridors, it becomes a critical option for maintaining continuity and avoiding costly product loss.
What Risks Are Associated With Increased Reliance on Air Freight?
As more shipments shift to air, capacity constraints can develop, particularly at major Gulf cargo hubs. This can lead to congestion, higher costs, and limited availability of specialized equipment such as active containers.
In addition, disruptions at key hubs can affect global connectivity, making alternative routing more complex. This creates a need for flexible planning and strong logistics partnerships to maintain control.
Get Logistics Insights by Email
Subscribe to our monthly market updates and get invited to exclusive webinars where our Freight Forwarding Experts answer all your questions on global trade.
When Do Charter Flights Become Essential for Life Sciences?
Charter flights become essential when commercial air freight capacity is insufficient or unreliable. For critical shipments such as vaccines, biologics, and clinical trial materials, dedicated aircraft provide guaranteed capacity, direct routing, and full control over transit conditions.
Charters are particularly valuable during peak disruption periods, enabling companies to bypass congested hubs and reduce transit times. While more costly, they offer unmatched reliability for mission-critical shipments.
How Do Multimodal Solutions Improve Resilience?
A multimodal approach combines ocean, road, air, and charter solutions to create a more resilient and flexible supply chain. By diversifying transport modes, companies can respond more effectively to disruptions and adjust strategies in real time.
For example, shipments may begin via ocean freight and then be escalated to air when delays occur. Similarly, charter solutions can be integrated into contingency plans for high-priority goods. This flexibility is essential in volatile environments.
10 Top Tips for Managing Multimodal Pharma Logistics During Disruption
- Assess product sensitivity and stability before selecting transport mode.
- Monitor transit conditions and disruption risks continuously.
- Plan alternative routing and mode options in advance.
- Use real-time visibility tools for informed decision-making.
- Build flexibility into supply chain strategies.
- Establish clear escalation criteria from ocean to air or charter.
- Validate packaging for multiple transport scenarios.
- Work with logistics partners with multimodal expertise.
- Maintain compliance across all regulatory frameworks.
- Conduct regular risk assessments of transport networks.
How Does DHL Enable Smart Mode Selection and Escalation?
DHL Global Forwarding supports pharmaceutical customers with advanced decision-making tools and deep regional expertise. Our teams continuously monitor disruptions across the MEA region and provide guidance on optimal transport modes based on real-time conditions.
We enable seamless transitions between ocean, air, road, and charter solutions, ensuring that shipments remain compliant and protected at every stage. Through strong airline partnerships, access to charter capacity, and robust multimodal networks, DHL ensures continuity even in complex scenarios.
Our experts also work closely with customers to assess risk, validate packaging, and ensure regulatory compliance when changing transport modes—helping to safeguard product integrity and accelerate delivery to patients.
Explore More Insights on the Life Science and Healthcare Sector
Global logistics solutions for the life sciences and healthcare sector, designed to ensure compliant, temperature‑controlled delivery, supply chain resilience, and patient safety worldwide.
Do You Have a Specific Shipping Challenge You Would like Help With?
Our Shipping Experts are ready to help